About Me

I'm a corporate partner based in London where I advise clients – ranging from start-ups to multinationals as well as venture capital and private equity funds – on mergers and acquisitions (and divestitures), securities transactions, private equity and venture capital investments/exits, joint ventures and corporate reorganisations.

I have extensive experience advising clients in a variety of sectors, with a particular emphasis on the life sciences and healthcare, technology, media and telecoms and retail and consumer sectors. Many of the transactions I advise on are in cutting-edge sub-sectors – which oftentimes require specialist legal expertise from experts across the firm – such as artificial intelligence (AI), biotech, blockchain, cyber, deep tech, health-tech, medical devices, quantum computing, software and robotics, among others.

You'll find me ranked in the Legal 500 UK 2024 legal directory as a Next Generation Partner in both the fields of Venture Capital and Life Sciences and Healthcare. I also advised on a number of transactions which helped the firm to win both the EMEA M&A Law Firm of the Year and the EMEA Venture Capital Law Firm of the Year awards at the LMG Life Sciences Awards EMEA 2023 in July 2023.

Clients retain me for my 20 years of experience and successful track record of executing transactions, as well as my focus on providing clients with pragmatic and commercial advice. Many of the transactions I am involved in are international in nature and I therefore have significant experience in solving complex cross-border legal issues and bridging cultural differences.

I am admitted as a Solicitor of the Senior Courts of England and Wales and the Eastern Caribbean Supreme Court in the British Virgin Islands and I hold an LL.B. in Law with Economics from Durham University. I also serve on the Finance and Tax Advisory Committee of the BioIndustry Association.
Experience
  • Life Sciences
  • Advised Envision Pharma Group on their acquisition of OKRA.ai, a technology company active in the provision of artificial intelligence (AI) solutions for the healthcare industry.
  • Advised Merck KGaA, as lead investor, on a series B financing into a UK life sciences company.
  • Advised the Dementia Discovery Fund (managed by SV Health Investors) on numerous transactions including: (i) Amphista Therapeutics Limited's series B extension financing; (ii) NeuroGeneus Limited's £12 million series A financing; and (iii) Transine Therapeutics Limited's £9.1 million seed financing.
  • Advised Brandon Capital, Atlas Ventures and Forbion on the US$68M series A financing of Pheon Therapeutics, a UK-based Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.
  • Advised Omnicell, Inc. on the acquisition of Hub and Spoke Innovations Limited, the distributor of the Pharmaself24 prescription collection kiosk in Great Britain.
  • Advised Railpen on its investment in CMR Surgical as part of the US$600 million series D financing led by SoftBank Vision Fund 2.
  • Advised Celltrion, Inc., Mirae Asset Capital and Premier Partners on the US$47 million series A financing of Iksuda Therapeutics Limited, the developer of a new generation of antibody drug conjugates (ADCs).
  • Advised Chiesi Farmaceutici S.p.A. on the in-licence of Raxone® – an orphan drug used in the treatment of Leber's hereditary optic neuropathy, a rare hereditary eye disease that leads to severe vision loss – from Santhera Pharmaceuticals Holding AG for approximately €93 million.
  • Technology, Media and Telecommunications
  • Advised Paladin Capital on multiple transactions including: (i) Hack The Box's US$55 million series B financing led by Carlyle; and (ii) Virtuoso's US$13.3m series A financing alongside Mubadala Capital.
  • Advised National Digital Infrastructure Fund, managed by Amber Infrastructure, on the sale of NextGenAccess Limited, the neutral-host managed fiber infrastructure service provider, to ITS Technology Group, a portfolio company of Aviva.
  • Advised Railpen on numerous transactions including their investments in: (i) Gousto (as part of a broader US$170 million secondary placing); and (ii) TransferMate (as part of its US$70M series C financing).
  • Advised Urban Air Port Limited on numerous transactions including: (i) its partnership with Hyundai Air Mobility (a Hyundai Motor Group division) to develop urban air mobility infrastructure; and (ii) multiple financings.
  • Advised Elite World Group, the world's largest model management network, on a joint venture to establish a new agency called EWG Virtual focused on creating digitized versions of real life talents and models.
  • Advised National Digital Infrastructure Fund and Railpen on the £50 million funding round in Community Fibre, the ultra-fast full-fibre internet service provider.
Education

Studied

  • Durham University, LLB, Law with Economics
  • BPP Law School, LPC

Admissions

  • The Senior Courts of England & Wales in 2006
  • Eastern Caribbean Supreme Court (British Virgin Islands) in 2014
Testimonials Carousel Megaphone

Testimonials

'James Baillieu is excellent, very commercial, and pro-active, bringing an assured confidence and calmness to the table.'

Legal 500 UK 2024 – Life Sciences & Healthcare

'Partner James Baillieu is … always on the ball, pragmatic, doesn't over complicate matters and very good at translating complex legal matters to business people.'

Legal 500 UK 2023 – Life Sciences & Healthcare

'James Baillieu is superb. He is quick and accurate in his responses, able to deal with minutae and grander strategy all with ease.'

Legal 500 UK 2023 – Venture Capital

Latest insights

More Insights
Car by beach

International expansion: using franchising to grow your brand abroad

Nov 07 2023

Read More
Snow-capped mountain range

London & the life sciences

Apr 28 2021

Read More
Curiosity line blue background

How does the National Security and Investment Bill impact your venture capital deal?

Feb 10 2021

Read More

News & Deals

More News & Deals

News

Bird & Bird advises Pret A Manger on strategic new partnership in the United States

Oct 23 2023

Read More

Deal

Bird & Bird advises Paladin Capital Group on Hack The Box's $55m Series B fundraising

Jan 18 2023

Read More

Deal

Bird & Bird advises the Dementia Discovery Fund on its investment into Amphista Therapeutics

Jan 05 2023

Read More

News

CVC International Trends and Practical tips to get it right

Oct 21 2020

Read More

Deal

Bird & Bird advises Elite World Group on new venture for the creation of digital talents and models

Aug 03 2020

Read More

News

Bird & Bird advises the National Digital Infrastructure Fund and RPMI Railpen on the £50 million funding round in Community Fibre

Jul 23 2019

Read More

What's on TwoBirds TV?

More Videos